@HCPLiveNews Associate Editor (Dermatology). Producer of #TheMedicalSisterhood and #SkinofColorSavvy podcasts. So extra, read all about it.
Joined January 2023
- Tweets168
- Following22
- Followers13
- Likes62
Tim S. retweeted
🚨BREAKING🚨
@FDA grants priority review to @TakedaPharma's zasocitinib drug for moderate-to-severe plaque psoriasis.
See what the phase 3 data showed: hcplive.com/view/fda-priorit…
Tim S. retweeted
It's day 2 at #LEADderm 2026! We're still on the ground in Newport Beach, CA, talking leadership, innovation, and what it takes to lead in dermatology today.🔎
Follow along: hcplive.com/clinical/dermato…
Tim S. retweeted
Are you attending LEADderm on Aug 29th-30th?🗓️
Founded by #dermatology leader Jennifer Soung, MD, this 2-day meeting pairs derm clinical updates with mentorship, negotiation, and career growth.
🔗See what's on deck: hcplive.com/view/conference-…
Tim S. retweeted
Weight loss or direct anti-inflammatory effect?
Dermatologists are still untangling how GLP-1 receptor agonists may be helping #psoriasis and #HS patients.
📽️Full video feature: hcplive.com/view/glp1s-derma…
Tim S. retweeted
June was a busy month in #dermatology.
📌 FDA approvals
📌 Conference coverage
📌 New psoriasis & atopic dermatitis data
📌 Podcast highlights
See the 8 biggest stories you may have missed:
hcplive.com/view/8-dermatolo…
Tim S. retweeted
The Revolutionizing Atopic Dermatitis (RAD) Conference 2026 is underway, and HCPLive is here!🤠
check out new expert interviews, clinical updates, emerging data, and key takeaways from one of the leading meetings in atopic dermatitis.
#RAD2026
🔗View: hcplive.com/conference/revol…
Tim S. retweeted
🚨NEW🚨
The @FDA has included #bemotrizinol as a permitted active ingredient in its list of over-the-counter (OTC) sunscreen products. This marks the first addition of an active ingredient to the sunscreen monograph since the late 1990s.☀️
🔗More here: hcplive.com/view/fda-adds-be…
I've put together a list of key news and podcast updates by @HCPLiveNews from May 2026 in dermatology.
Check out this list to see what you missed in May!☑️
From new psoriasis and atopic dermatitis data to discussions on health equity, patient engagement, and physician well-being, May was a busy month in dermatology.
Catch up on 7 dermatology headlines you may have missed from May 2026: hcplive.com/view/7-dermatolo…
#Dermatology
Tim S. retweeted
🚨NEW🚨
A supplemental New Drug Application (sNDA) has been submitted by @ArcutisBio to the #FDA to broaden the indication of roflumilast cream 0.05% (Zoryve) for mild to moderate atopic dermatitis in infants down to 3 months of age.
🔗More:
hcplive.com/view/roflumilast…
Tim S. retweeted
🚨NEW🚨
@US_FDA expands dupilumab (Dupixent) to children aged 2–11 with uncontrolled chronic spontaneous urticaria (CSU)—the first biologic approved for this population in the US.
Read more: hcplive.com/view/fda-expands…
Tim S. retweeted
New on the #SkinofColorSavvy podcast 🎧...
Dr. Vinod Nambudiri of @BrighamWomens, discusses the expanding AAD clinical image collection—addressing gaps in skin tone representation and improving diagnostic accuracy.
🔗 hcplive.com/view/skin-of-col…
#Dermatology #AAD2026
My wrap-up of Q1 2026 (January-March) in the biggest dermatology news headlines covered by @HCPLiveNews is out.
Worth a read: hcplive.com/view/q1-2026-rec…
Are you caught up on news in #dermatology covered by HCPLive's team in Q1 of 2026?🗒️
If not, this review is for you! Check out our Q1 summary, covering @US_FDA news, new late stage data, and podcast updates.
🔗View here: hcplive.com/view/q1-2026-rec…
Tim S. retweeted
March was anything but quiet in dermatology 👀
Head-to-head trial shakeups, long-term data, and FDA movement all made waves at #AAD2026.
What could this mean for psoriasis & atopic dermatitis care?
Read more: hcplive.com/view/6-dermatolo…
AAD 2026 delivered a lot in psoriasis 👀
From next-gen oral TYK2 inhibitors to long-term biologic data and new insights in nail psoriasis + GPP—some key trials could shape where treatment is headed next.
I rounded up 6 you should know:
hcplive.com/view/aad-2026-6-…
Tim S. retweeted
Day 2️⃣ of #AAD2026 coverage is LIVE! 🎙️ We're on the ground in Denver bringing you the latest interviews, data, and insights from the Annual Meeting. Stay tuned — more is coming all day. 👇
hcplive.com/conference/aad
Wow, #AAD2026 is busy (as always)!
This conference floor is massive as well.
Check out our updates for @HCPLiveNews's coverage of new dermatology data and interviews with trial investigators: hcplive.com/conference/aad
#HealthNews #SkinHealth
Such a great, impassioned speech about the work being done here at the @SkinOfColor Scientific Symposium!🌟
Susan Taylor, MD, founder of @SkinOfColor, opened the SOCS Scientific Symposium with an inspiring call to action for dermatologists and healthcare leaders to stand firm on health equity — even in turbulent times.
#AAD2026 #SkinOfColor
🔗 hcplive.com/conference/aad
I'm here for @HCPLiveNews covering the 22nd Annual SOCS Scientific Symposium (@SkinOfColor)!
It's a busy meeting, with lots of great talks. So many future leaders in dermatology here!
I have landed and am in Denver for the @AADskin Annual Meeting and the @SkinOfColor Symposium...
It's hotter in Colorado than I anticipated.🌤️
Follow my posts for the next few days for updates at these meetings!
Heading to Denver for #AAD2026 tmmw—if anyone needs me, I'll be the one joining the airport lines with half the dermatology world. ✈️
Kicking off at the @SkinOfColor (SOCS) Scientific Symposium, then covering late-breaking data and interviews for @HCPLiveNews. Stay tuned! 👋
